➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Express Scripts
McKinsey
Boehringer Ingelheim
Baxter

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

INFANT'S ADVIL Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Infant's Advil, and when can generic versions of Infant's Advil launch?

Infant's Advil is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in INFANT'S ADVIL is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and twenty suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

US ANDA Litigation and Generic Entry Outlook for Infant's Advil

A generic version of INFANT'S ADVIL was approved as ibuprofen by OHM on July 15th, 1986.

  Start Trial

Summary for INFANT'S ADVIL
Drug patent expirations by year for INFANT'S ADVIL
Recent Clinical Trials for INFANT'S ADVIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityN/A
University of Alabama at BirminghamEarly Phase 1
Catherine ChappellPhase 1

See all INFANT'S ADVIL clinical trials

US Patents and Regulatory Information for INFANT'S ADVIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline INFANT'S ADVIL ibuprofen SUSPENSION/DROPS;ORAL 020812-002 Jan 12, 2000 OTC Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Express Scripts
McKinsey
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.